You can now read 10 articles each month for free on BostonGlobe.com.

The Boston Globe

Business

Boston Capital

How the little biotech guys beat big odds

Mergers and acquisitions of life science companies that find their way into this space normally involve some combination of famous executives, billions of dollars, or the commercial fate of a medical miracle.

This one is different. Chances are you’ve never heard of Semprus Biosciences of Cambridge or the bigger company that bought it Monday for relatively modest money. The medical technology, though important, is no miracle. The main reason Semprus chief executive David Lucchino’s name may ring a bell is that he happens to be the nephew of Boston Red Sox president Larry Lucchino.

Loading comments...

You have reached the limit of 10 free articles a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than $1 a week